Please ensure Javascript is enabled for purposes of website accessibility

New York State Legalizes Recreational Marijuana

By Eric Volkman - Updated Apr 1, 2021 at 9:39AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The wave of U.S. cannabis reform washes over one of the largest states.

On Wednesday, New York State sanctioned the sale and consumption of recreational (also known as "adult use") cannabis when Gov. Andrew Cuomo signed a sweeping legalization bill into law. This occurred one day after it was overwhelmingly approved by the state's legislature.

New York is now the 16th state to have approved recreational marijuana (Washington D.C., at present not a state, has also done so).

Among numerous other measures, the sprawling law allows for a degree of home cultivation for individuals, generous licensing terms for societal groups disproportionally affected by the state's previously tough anti-drug legislation, expungement in qualifying cases for violations of those old laws, and the expansion of qualifications for people to obtain medical cannabis.

Paper ballot under bowl of cannabis flowers.

Image source: Getty Images.

One unique aspect to New York's new marijuana liberalization is that it allows for the public consumption of the drug, albeit with some caveats. For example, it is prohibited at locations that currently bar cigarette smoking by state law, such as school grounds.

Proponents of the law, such as Cuomo, said that taxes from legal weed could amount to $350 million per year for the budget-challenged state. It could also create 30,000 to 60,000 jobs.

Very few publicly traded marijuana companies are active in the state so far, but that's almost certain to change. One operator on the scene is Cresco Labs (CRLBF 1.10%), which has four of its Sunnyside* dispensaries scattered throughout New York State and, as such, will certainly be a company for marijuana stock investors to watch.

Not surprisingly, Cresco is enthusiastic about the new law. "The legislation passed today significantly expanding the medical program and legalizing adult-use cannabis in New York represents a massive domino falling in what has been a steady march toward acceptance and legalization of cannabis nationwide," Cresco quoted CEO Charlie Bachtell as saying.

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$3.94 (1.10%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
345%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.